Records containing: Tuberculosis, Pulmonary
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-05-01A Randomised, Controlled, Open-Label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients With Pulmonary Multidrug Resistant Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-04-30Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis.
-
CLINICAL_TRIALS study record update · 2024-04-16Bronchoalveolar Lavage Using a Conventional Bronchoscope vs. Bronchial Washing Using a Thin Bronchoscope to Diagnose Pulmonary Tuberculosis: a Prospective Randomized Trial
-
CLINICAL_TRIALS study record update · 2024-04-05Combined Phone Based Video DOT and Mobile Payments for TB Treatment in Cambodia
-
CLINICAL_TRIALS study record update · 2024-03-25Phase 2b Randomized Double-blind, Placebo-controlled Trial to Estimate the Potential Efficacy and Safety of Two Repurposed Drugs, Acetylsalicylic Acid and Ibuprofen, for Use as Adjunct Therapy Added to, and Compared With, the Standard WHO-recommended TB Regimen (SMA-TB)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-02-26A Prospective, Randomized Pilot Study of the Immunomodulatory Effects of Azithromycin in Adults With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-02-13Cross-sectional Study on Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students. A GENERATOR Infrastructure.
-
CLINICAL_TRIALS study record update · 2024-01-25A I//II Phase Study of the Efficacy and Safety of Interferon-Gamma by Subcutaneous Injection in the Complex Treatment of Patients Infected With HIV and Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-01-05A Prospective Multicenter Phase II-study: Pharmacokinetics and Safety of High-Dose Rifampicin and Pyrazinamide in a Shorter Tuberculosis Treatment Compared With Standardized Treatment in Patients With Mild to Moderate Pulmonary TB
-
CLINICAL_TRIALS study record update · 2024-01-05Multi-centric Prospective Cohort Study of TB Recurrence Free Cure Among Microbiologically Confirmed New Pulmonary Tuberculosis Patients Treated Under NTEP With the 4-month Moxifloxacin Containing Daily Regimen
-
CLINICAL_TRIALS study record update · 2023-12-22A Phase IIb, Open-Label, Randomized Controlled Dose Ranging Multi-Center Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Exposure-Response Relationship of Different Doses of BTZ-043 in Combination With Bedaquiline and Delamanid in Adult Subjects With Newly Diagnosed, Uncomplicated, Drug-sensitive Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2023-12-14Effect of Breathing Exercise on Fatigue in Patients With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2023-12-13Personalized Therapy Durations Defined by the Blood RNA-based Model for Individualizing Treatment in Multidrug-Resistant Tuberculosis
-
CLINICAL_TRIALS study record update · 2023-12-11Efficacy and Safety of Short-course Treatment for Drug-sensitive Tuberculosis in China
-
CLINICAL_TRIALS study record update · 2023-12-08Repurposing a Lipid Lowering Drug to Treat Tuberculosis: Effectiveness of Statins as Adjuvant to Treatment of Pulmonary Tuberculosis in Nigeria
-
CLINICAL_TRIALS study record update · 2023-11-21A Single-centre, Open-label, Exploratory Study to Investigate the Pharmacokinetics of Ethionamide and Ethionamide Sulfoxide in Patients Established on Treatment for Tuberculosis.
-
CLINICAL_TRIALS study record update · 2023-11-18Tuberculosis Cohort Avicenne Hospital
-
CLINICAL_TRIALS study record update · 2023-11-08An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)
-
CLINICAL_TRIALS study record update · 2023-09-13Evaluating the Sequelae of Pulmonary Tuberculosis in Gambian Children
-
CLINICAL_TRIALS study record update · 2023-09-11Nutritional Supplement Trial in Patients With Tuberculosis to Improve Anthropometry and Treatment Outcome
-
CLINICAL_TRIALS study record update · 2023-08-14Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
-
CLINICAL_TRIALS study record update · 2023-08-08Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
-
CLINICAL_TRIALS study record update · 2023-07-19A Phase 2a Study of the Early Bactericidal Activity of Rifampin (RIF) in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampin-resistant or Rifampin-susceptible Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2023-06-29A Phase 3 Partially-blinded, Randomized Trial Assessing the Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary Infection of Either Extensively Drug-resistant Tuberculosis (XDR-TB), Pre-XDR-TB or Treatment Intolerant or Non-responsive Multi-drug Resistant Tuberculosis (MDR-TB)
-
CLINICAL_TRIALS study record update · 2023-06-26Early Bactericidal Activity of Cephalexin and Amoxicillin-clavulanate for Susceptible Tuberculosis - BLAST 1 Trial